113 related articles for article (PubMed ID: 7505752)
1. The effect of iloprost in patients with rest pain.
Volteas N; Leon M; Labropoulos N; Christopoulos D; Boxer D; Nicolaides A
Eur J Vasc Surg; 1993 Nov; 7(6):654-8. PubMed ID: 7505752
[TBL] [Abstract][Full Text] [Related]
2. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
3. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
[TBL] [Abstract][Full Text] [Related]
4. Favorable clinical effects of iloprost infusion in 4 uremic patients with critical limb ischemia.
Bedani PL; Perini L; Farinelli R; Fabbian F; Fiocchi O; Guerra S; Vanini A; Gilli P
Angiology; 1992 May; 43(5):408-11. PubMed ID: 1373589
[TBL] [Abstract][Full Text] [Related]
5. [A new infusion method for a prostacyclin analogue].
Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G
Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
[TBL] [Abstract][Full Text] [Related]
6. [The role of iloprost in the treatment of critical ischemia of the limbs].
Poggesi L; Comeglio M
Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
[TBL] [Abstract][Full Text] [Related]
7. Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin.
Pancera P; Minuz P; Rossi L; Ribul M; Arosio E; Lechi A
Angiology; 1997 Feb; 48(2):149-55. PubMed ID: 9040270
[TBL] [Abstract][Full Text] [Related]
8. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
9. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
10. Effects of iloprost and factors affecting outcome in patients with severe inoperable lower limb ischaemia. U.K. Severe Limb Ischaemia Study Group.
Belcher G
Agents Actions Suppl; 1992; 37():354-60. PubMed ID: 1378690
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
12. Intravenous iloprost increases mesenteric blood flow in experimental acute nonocclusive mesenteric ischemia.
Kang H; Manasia A; Rajamani S; Rajaram SS; Hannon E; Lu Y; Oropello JM; Benjamin E
Crit Care Med; 2002 Nov; 30(11):2528-34. PubMed ID: 12441765
[TBL] [Abstract][Full Text] [Related]
13. Accidental intra-arterial drug injection successfully treated with Iloprost.
Samuel I; Bishop CC; Jamieson CW
Eur J Vasc Surg; 1993 Jan; 7(1):93-4. PubMed ID: 7681017
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic effects of iloprost in patients with lower limb ischemia.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of prostanoids in patients with critical leg ischemia].
Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
[TBL] [Abstract][Full Text] [Related]
16. [Iloprost for severe Raynaud's phenomenon and ischaemic ulcers related with systemic diseases].
García Hernández FJ; Ocaña Medina C; Mateos Romero L; Molinillo López J; Arias Zambrano A; González León R; Sánchez Román J
Med Clin (Barc); 2004 Apr; 122(13):501-4. PubMed ID: 15104947
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
[TBL] [Abstract][Full Text] [Related]
18. Treatment of limb threatening ischaemia with intravenous iloprost: a randomised double-blind placebo controlled study. U.K. Severe Limb Ischaemia Study Group.
Eur J Vasc Surg; 1991 Oct; 5(5):511-6. PubMed ID: 1720403
[TBL] [Abstract][Full Text] [Related]
19. A stable prostacyclin analogue (iloprost) in the treatment of Buerger's disease: a prospective analysis of 150 patients.
Bozkurt AK; Cengiz K; Arslan C; Mine DY; Oner S; Deniz DB; Ufuk D
Ann Thorac Cardiovasc Surg; 2013; 19(2):120-5. PubMed ID: 22971807
[TBL] [Abstract][Full Text] [Related]
20. [Our experience in using a synthetic prostacyclin analog in the treatment of critical ischemia of the extremities].
Centorrino T; Versaci A; Ciccolo A; Terranova ML; Panté S; Barbera A; Cuzzocrea D
G Chir; 1998 Oct; 19(10):399-403. PubMed ID: 9835185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
